Rankin Amy J, Sebbag Lionel, Bello Nora M, Crumley William R, Allbaugh Rachel A
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.
Am J Vet Res. 2013 Feb;74(2):262-7. doi: 10.2460/ajvr.74.2.262.
To assess inhibitory effects of orally administered anti-inflammatory medications on paracentesis-induced intraocular inflammation in clinically normal cats.
30 clinically normal domestic shorthair cats.
Cats were randomly assigned to a control group and 4 treatment groups. Cats in the treatment groups received an anti-inflammatory medication orally once daily at 7 AM (acetylsalicylic acid [40.5 mg/cat], meloxicam [0.1 mg/kg], prednisone [5 mg/cat], or prednisolone [5 mg/cat]) for 5 days beginning 2 days before paracentesis-induced breakdown of the blood-aqueous barrier (BAB) and continuing until 2 days after paracentesis. Paracentesis of the anterior chamber was performed in 1 randomly selected eye of each cat. Fluorophotometry was performed in both eyes of each cat immediately before (time 0) and 6, 24, and 48 hours after paracentesis.
At 24 and 48 hours after paracentesis, fluorescein concentration in the eye subjected to paracentesis in the cats receiving prednisolone was decreased, compared with that in the control cats. At 48 hours, a decrease in the fluorescein concentration was also apparent in the eye subjected to paracentesis in the cats receiving meloxicam, compared with that in the control cats. There was no evidence of treatment effects for acetylsalicylic acid or prednisone. There was no evidence of treatment effects in eyes not subjected to paracentesis.
Orally administered prednisolone and meloxicam significantly decreased intraocular inflammation in clinically normal cats with paracentesis-induced BAB breakdown. Oral administration of prednisolone or meloxicam may be an effective treatment for cats with uveitis.
评估口服抗炎药物对临床正常猫经前房穿刺诱导的眼内炎症的抑制作用。
30只临床正常的家养短毛猫。
将猫随机分为对照组和4个治疗组。治疗组的猫在经前房穿刺诱导血-房水屏障(BAB)破坏前2天开始,每天上午7点口服一次抗炎药物(乙酰水杨酸[40.5毫克/只猫]、美洛昔康[0.1毫克/千克]、泼尼松[5毫克/只猫]或泼尼松龙[5毫克/只猫]),持续5天,直至经前房穿刺后2天。对每只猫的1只随机选择的眼睛进行前房穿刺。在每只猫的双眼于前房穿刺前(时间0)以及穿刺后6、24和48小时进行荧光光度测定。
与对照组猫相比,在经前房穿刺的眼睛中,接受泼尼松龙治疗的猫在穿刺后24和48小时时荧光素浓度降低。在穿刺后48小时,与对照组猫相比,接受美洛昔康治疗的猫经前房穿刺的眼睛中荧光素浓度也明显降低。未发现乙酰水杨酸或泼尼松有治疗效果的证据。在未进行前房穿刺的眼睛中未发现治疗效果的证据。
口服泼尼松龙和美洛昔康可显著降低临床正常猫经前房穿刺诱导的BAB破坏后的眼内炎症。口服泼尼松龙或美洛昔康可能是治疗葡萄膜炎猫的有效方法。